| dc.contributor | https://orcid.org/0000-0003-1324-4488 | |
| dc.creator | Muñoz Carrillo, José Luís | |
| dc.creator | Maldonado Tapia, Claudia | |
| dc.creator | López Luna, Argelia | |
| dc.creator | Muñoz Escobedo, José Jesús | |
| dc.creator | Flores de la Torre, Juan Armando | |
| dc.creator | Moreno García, María Alejandra | |
| dc.date.accessioned | 2019-02-27T18:40:39Z | |
| dc.date.available | 2019-02-27T18:40:39Z | |
| dc.date.created | 2019-02-27T18:40:39Z | |
| dc.date.issued | 2018-11-05 | |
| dc.identifier | http://localhost/xmlui/handle/20.500.11845/677 | |
| dc.identifier | https://doi.org/10.48779/xjfd-vk77 | |
| dc.description.abstract | Currently, it is estimated that more than 11 million humans in the world are infected by helminth parasites of Trichinella species, mainly by Trichinella spiralis (T. spiralis), responsible for causing Trichinellosis disease in both animals and humans. Trichinellosis is a cosmopolitan parasitic zoonotic disease, which has direct relevance to human and animal health, because it presents a constant and important challenge to the host’s immune system, especially through the intestinal tract. Currently, there is an intense investigation of new strategies in pharmacotherapy and immunotherapy against infection by Trichinella spiralis. In this chapter, we will present the most current aspects of biology, epidemiology, immunology, clinicopathology, pharmacotherapy and immunotherapy in Trichinellosis. | |
| dc.language | spa | |
| dc.publisher | IntechOpen | |
| dc.relation | generalPublic | |
| dc.relation | https://www.intechopen.com/online-first/current-aspects-in-trichinellosis | |
| dc.rights | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | |
| dc.rights | Atribución-NoComercial-CompartirIgual 3.0 Estados Unidos de América | |
| dc.source | Parasitology [Working Title], IntechOpen | |
| dc.title | Current aspects in Trichinellosis | |
| dc.type | info:eu-repo/semantics/bookPart | |
